{"id":"W2894989600","doi":"10.1093/nop/npy039","title":"Proposed diagnostic and treatment paradigm for high-grade neurological complications of immune checkpoint inhibitors","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology Practice","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Pembrolizumab; Myasthenia gravis; Adverse effect; Immune checkpoint; Immune system; Myelitis; Oncology; Internal medicine; Immunology; Immunotherapy; Spinal cord","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005133742,0.0005638066,0.002452939,0.0001739458,0.0001676116,0.00001960467,0.0001465319,0.0004590871,0.00002581865],"category_scores_gemma":[0.005631444,0.0003783291,0.0005715712,0.0002327916,0.0004723861,0.00008561248,0.0001094244,0.0004358297,0.00003756745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002091667,"about_ca_system_score_gemma":0.0006259599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006145985,"about_ca_topic_score_gemma":0.000008119357,"domain_scores_codex":[0.9963963,0.0009362884,0.001236124,0.0008504253,0.0001915489,0.0003893286],"domain_scores_gemma":[0.9793606,0.01807155,0.001442988,0.0007462957,0.0001531684,0.0002253756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008107486,0.009096179,0.00005729678,0.005725293,0.002224867,0.0008080635,0.0001209438,6.514414e-7,0.00008504417,0.003298543,0.001673203,0.9760992],"study_design_scores_gemma":[0.003166104,0.01703543,0.0002460867,0.0006068719,0.01263826,0.002689375,0.00001536399,0.000006141671,0.00006929782,0.0001164045,0.963196,0.0002147085],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006508806,0.9780239,0.00007066267,0.01195847,0.0005659652,0.008135891,0.000247886,0.00007623352,0.0002701136],"genre_scores_gemma":[0.0007833216,0.9894448,0.006630431,0.0007107075,0.0003738149,0.001504676,0.0004367876,0.00007869833,0.00003678065],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9758844,"threshold_uncertainty_score":0.9998668,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08427140323032882,"score_gpt":0.3896673795599873,"score_spread":0.3053959763296585,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}